Literature DB >> 2511208

Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein.

H Morreau1, N J Galjart, N Gillemans, R Willemsen, G T van der Horst, A d'Azzo.   

Abstract

We have isolated two cDNAs encoding human lysosomal beta-galactosidase, the enzyme deficient in GM1-gangliosidosis and Morquio B syndrome, and a beta-galactosidase-related protein. In total RNA from normal fibroblasts a major mRNA of about 2.5 kilobases (kb) is recognized by cDNA probes. A minor transcript of about 2.0 kb is visible only in immunoselected polysomal RNA. A heterogeneous pattern of expression of the 2.5-kb beta-galactosidase transcript is observed in fibroblasts from different GM1-gangliosidosis patients. The nucleotide sequences of the two cDNAs are extensively colinear. However, the short cDNA misses two noncontiguous protein-encoding regions (1 and 2) present in the long cDNA. The exclusion of region 1 in the short molecule introduces a frameshift in its 3'-flanking sequence, which is restored by the exclusion of region 2. These findings imply the existence of two mRNA templates, which are read in a different frame only in the nucleotide stretch between regions 1 and 2. Sequence analysis of genomic exons of the beta-galactosidase gene shows that the short mRNA is generated by alternative splicing. The long and short cDNAs direct the synthesis in COS-1 cells of beta-galactosidase polypeptides of 85 and 68 kDa, respectively. Only the long protein is catalytically active under the assay conditions used, and it is capable of correcting beta-galactosidase activity after endocytosis by GM1-gangliosidosis fibroblasts. The subcellular localization of cDNA-encoded beta-galactosidase and beta-galactosidase-related proteins is different.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511208

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.

Authors:  S Zhang; R Bagshaw; W Hilson; Y Oho; A Hinek; J T Clarke; J W Callahan
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Partial amino acid sequence and mRNA analysis of cytosolic pyridoxine-beta-D-glucoside hydrolase from porcine intestinal mucosa: proposed derivation from the lactase-phlorizin hydrolase gene.

Authors:  Chi-Wah Tseung; Laura G McMahon; Jorge Vázquez; Jan Pohl; Jesse F Gregory
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

3.  Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo.

Authors:  Murray A Cotter; Scott R Florell; Sancy A Leachman; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2007-05-24       Impact factor: 8.551

4.  Constant splice-isoform ratios in human lymphoblastoid cells support the concept of a splico-stat.

Authors:  Marcel Kramer; Klaus Huse; Uwe Menzel; Oliver Backhaus; Philip Rosenstiel; Stefan Schreiber; Jochen Hampe; Matthias Platzer
Journal:  Genetics       Date:  2011-01-10       Impact factor: 4.562

Review 5.  The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

Authors:  Debra S Regier; Richard L Proia; Alessandra D'Azzo; Cynthia J Tifft
Journal:  Pediatr Endocrinol Rev       Date:  2016-06

6.  Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient.

Authors:  Anna Caciotti; Tiziana Bardelli; John Cunningham; Alessandra D'Azzo; Enrico Zammarchi; Amelia Morrone
Journal:  Hum Genet       Date:  2003-03-19       Impact factor: 4.132

7.  Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis.

Authors:  S Chakraborty; M A Rafi; D A Wenger
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

8.  Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity.

Authors:  Chi-Fan Yang; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-09-30       Impact factor: 8.410

9.  Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients.

Authors:  R M Boustany; W H Qian; K Suzuki
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

10.  SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing.

Authors:  Raül Santamaria; Lluïsa Vilageliu; Daniel Grinberg
Journal:  BMC Res Notes       Date:  2008-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.